文献速递细菌感染、耐药与抗菌药物

革兰阴性菌血流感染随访血培养与预后相关

Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study.
PubMed 文献 · Clin Microbiol Infect · 2020-01-30

该回顾性队列纳入2013—2016年某三级医院1576例单微生物革兰阴性菌血流感染成人患者,278例(17.6%)在初始血培养后24小时至7天行随访血培养。随访血培养与30天死亡率降低相关(HR 0.48),并在274对匹配患者中得到证实。

要点

  • 随访血培养多用于病情更重、非泌尿来源及耐药菌感染患者。
  • 278例随访血培养患者中107例(38.5%)存在持续性血流感染。
  • 匹配分析确认随访血培养与更低死亡率相关。

核心结论

  • 在革兰阴性菌血流感染中,随访血培养与30天死亡率降低相关(HR 0.48),并在274对匹配患者中得到证实。

研究设计与样本

  • 回顾性观察性队列研究,纳入2013—2016年某三级教学医院1576例单微生物革兰阴性菌血流感染成人患者。
  • 暴露变量为初始血培养后24小时至7天实施的随访血培养,采用多因素Cox分析并以时间依赖协变量处理。

主要发现

  • 278例(17.6%)患者实施随访血培养,中位时间为初始血培养后3天、启动有效抗生素治疗后2天。
  • 随访血培养患者中107例(38.5%)存在持续性血流感染。
  • 30天死亡率为10.4%,随访血培养与死亡率降低独立相关(HR 0.48)。
  • 死亡的独立危险因素包括Charlson合并症指数(HR 1.12)、SOFA(HR 1.11)、感染性休克(HR 2.64)、中心静脉导管来源(HR 2.30)、复杂性血流感染(HR 2.10)、碳青霉烯耐药(HR 2.34)。
  • 泌尿来源(HR 0.60)、有效经验性治疗(HR 0.68)和感染源控制(HR 0.34)与死亡率降低相关。

临床怎么用

  • 对病情较重、非泌尿来源或耐药菌感染的革兰阴性菌血流感染患者可考虑随访血培养,以识别持续性感染并指导治疗。
  • 随访血培养应与感染源控制和感染科会诊结合评估,不能单独作为改善预后的措施。

局限性

  • 为单中心回顾性观察性研究,随访血培养的选择存在适应证偏倚,虽经匹配分析仍不能完全排除混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We examined factors associated with follow-up blood cultures (FUBCs) in patients with monomicrobial Gram-negative (GN) bloodstream infection (BSI) and investigated the impact of FUBCs on therapeutic management and patient outcome. METHODS: A retrospective cohort analysis was conducted of adult patients diagnosed with GN-BSI at a tertiary-care university hospital during 2013-2016. FUBCs performed between 24 hours and 7 days after index BCs was the exposure variable. Risk factors for 30-day mortality were analysed by multivariate Cox analysis on the overall cohort, including FUBCs as a time-varying covariate and on 1:1 matched patients according to Sequential Organ Failure Assessment (SOFA) score and time to FUBC. RESULTS: In 278 (17.6%) of 1576 patients, FUBCs were performed within a median of 3 and 2 days after index BCs and active antibiotic therapy initiation. Persistent BSI was found in 107 (38.5%) of 278 patients. FUBCs were performed in more severely ill patients, with nonurinary sources, difficult-to-treat pathogens and receipt of initial inappropriate therapy. Source control and infectious disease consultation rates were higher among patients with preceding FUBCs and was associated with longer treatment duration. Thirty-day mortality was 10.4%. Independent risk factors for mortality were Charlson comorbidity index (hazard ratio (HR) 1.12) SOFA (HR 1.11), septic shock (HR 2.64), urinary source (HR 0.60), central venous catheter source (HR 2.30), complicated BSI (HR 2.10), carbapenem resistance (HR 2.34), active empiric therapy (HR 0.68), source control (HR 0.34) and FUBCs (HR 0.48). Association between FUBCs and lower mortality was confirmed in the 274 matched pairs. CONCLUSIONS: FUBCs were performed in more severe GN-BSIs, yielding a high rate of persistent BSI. In this context, FUBCs were associated with lower mortality.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Giannella M, Pascale R, Pancaldi L, et al. Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study. Clin Microbiol Infect. 2020. PMID: 32006697. doi:10.1016/j.cmi.2020.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。